Table 2.
Antimicrobial activity expressed as inhibition diameter zones in millimeters (mm) of chemical compounds against the pathological strains based on well diffusion assay.
| Chem. compd. | Gram-positive bacteria | Gram-negative bacteria | Yeast | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Staphylococcus aureus ATCC29213 | B. subtilis ATCC6633 | B. megaterium ATCC9885 | Sarcina lutea | Klebsiella pneumoniae ATCC13883 | Pseudomonas aeruginosa ATCC27953 | E. coli ATCC25922 | Saccharomyces cerevisiae | Candida albicans NRRL Y-477 | |
| 5 | 18 | 17 | 20 | 23 | 24 | 23 | 24 | 22 | 18 |
| 8a | 19 | 16 | 18 | 18 | 17 | 19 | 23 | 20 | 18 |
| 8b | 19 | 18 | 17 | 28 | 18 | 19 | 24 | 21 | 18 |
| 8c | 25 | 26 | 23 | 30 | 34 | 33 | 31 | 22 | 23 |
| 8d | 23 | 12 | 17 | 18 | 16 | 18 | 24 | 20 | 18 |
| 13a | 22 | 18 | 28 | 21 | 23 | 19 | 23 | 20 | 16 |
| 13b | 20 | 18 | 19 | 22 | 20 | 21 | 24 | 19 | 16 |
| 14 | 19 | 18 | 20 | 23 | 22 | 22 | 25 | 24 | 20 |
| 15 | 20 | 17 | 20 | 24 | 21 | 19 | 25 | 20 | 18 |
| 16 | 19 | 16 | 21 | 20 | 21 | 20 | 27 | 21 | 16 |
| Ciprofloxacin | 20 | 22 | 24 | 20 | 25 | 24 | 23 | N.A. | N.A. |
| Ketoconazole | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | 23 | 22 |
The experiment was carried out in triplicate, and the average zone of inhibition was calculated; N.A. (no activity).